Products / PRODUCT LIST

API PRODUCT PORTFOLIO

Inke's products are high-added-value active pharmaceutical ingredients (APIs),
mainly for use in respiratory inhalation and CNS therapies

API	Indication	Micronised	EU DMF
Abediterol	Asthma and COPD
Aclidinium bromide	COPD
Batefenterol	COPD
Brexpiprazole	Schizophrenia and major depressive disorders
Brivaracetam	Antiepileptic
Clomethiazole	Insomnia		•
Crisaborole^p	Atopic dermatitis and psoriasis
Imidafenacin^p	Urinary incontinence
Luliconazole^p	Antifungal
Olodaterol^p	COPD	•
Revefenacin	COPD
Rivaroxaban^p	Thrombosis. Stroke	•
Roflumilast	COPD with chronic bronchitis
Salbutamol / Albuterol sulfate	Asthma and COPD
Tolvaptan	Hiponatremia
Umeclidinium bromide	COPD	•
Vilanterol trifenatate	Asthma and COPD

DOWNLOAD INKE APIs PRODUCT LIST

P = Patent applications/granted patents owned by Neuraxpharm

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

See Neuraxpharm’s sites

API PRODUCT PORTFOLIO